Stocks
AquaBounty Technologies, Inc.AQB
NASDAQHealthcareBiotechnology$0.94-2.40%
Focused on land-based aquaculture, this biotech firm develops genetically engineered Atlantic salmon designed for faster growth. The company operates in a highly regulated space, with its AquAdvantage Salmon being the first GM animal approved for human consumption in the U.S. Investors monitor its progress as a pioneer in sustainable protein solutions amid ongoing debates about GMO foods.
Market Cap: $3.6M52W Range: $0.49 – $2.95
Congressional Interest in AquaBounty Technologies, Inc. (AQB)
1 member of Congress has disclosed 1 trade in AquaBounty Technologies, Inc. (AQB), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading AQB?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-06-29 | Christopher L. Jacobs | buy | $1K – $15K |